6:13 PM
Sep 10, 2012
 |  BC Extra  |  Company News

FDA panel to discuss raxibacumab for anthrax

FDA's Anti-Infective Drugs Advisory Committee will meet on Nov. 2 to discuss a BLA from Human Genome Sciences Inc. for raxibacumab to...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >